Pacific Biosciences Of California (PACB) Gross Margin (2010 - 2026)
Pacific Biosciences Of California's quarterly Gross Margin came in at 34.54% in Q1 2026, up 3823.0% year-on-year from 0.88% in Q1 2025, and down 6.92% quarter-over-quarter from 37.11% in Q4 2025.
Pacific Biosciences Of California has reported Gross Margin for 17 years, with the latest figure at 34.54% in Q1 2026.
- For the quarter ending Q1 2026, Gross Margin rose 3823.0% year-over-year to 34.54%; the trailing twelve-month figure through Mar 2026 stood at 37.49% (up 2132.0% YoY), and the FY2025 full-year result was 28.61%, up 440.0% from the prior year.
- Gross Margin for Q1 2026 stood at 34.54%, down from 37.11% in the prior quarter.
- The five-year high for Gross Margin was 45.66% in Q2 2022, with the low at 3.69% in Q1 2025.
- Average Gross Margin over 5 years is 29.28%, with a median of 32.15% recorded in 2023.
- Year-over-year, Gross Margin plunged 3276 bps in 2025 and surged 3823 bps in 2026.
- Tracing PACB's Gross Margin over 5 years: stood at 18.79% in 2022, then decreased by 13 bps to 16.4% in 2023, then surged by 56 bps to 25.64% in 2024, then jumped by 45 bps to 37.11% in 2025, then fell by 7 bps to 34.54% in 2026.
- The last three Gross Margin figures came in at 34.54% (Q1 2026), 37.11% (Q4 2025), and 41.36% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 63.83% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 78.01% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 45.22% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 62.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 38.53% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 43.89% |
| 10 | Pacific Biosciences Of California | 481.66 Mn | 205.70 Mn | 12.84 Mn | 34.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.54% |
| Dec 31, 2025 | 37.11% |
| Sep 30, 2025 | 41.36% |
| Jun 30, 2025 | 36.93% |
| Mar 31, 2025 | -3.69% |
| Dec 31, 2024 | 25.64% |
| Sep 30, 2024 | 25.03% |
| Jun 30, 2024 | 16.49% |
| Mar 31, 2024 | 29.07% |
| Dec 31, 2023 | 16.40% |
| Sep 30, 2023 | 32.15% |
| Jun 30, 2023 | 32.68% |
| Mar 31, 2023 | 25.09% |
| Dec 31, 2022 | 18.79% |
| Sep 30, 2022 | 41.93% |
| Jun 30, 2022 | 45.66% |
| Mar 31, 2022 | 42.67% |
| Dec 31, 2021 | 46.55% |
| Jun 30, 2021 | 44.93% |
| Mar 31, 2021 | 44.75% |
| Dec 31, 2020 | 42.01% |
| Sep 30, 2020 | 37.02% |
| Jun 30, 2020 | 38.72% |
| Mar 31, 2020 | 48.01% |
| Dec 31, 2019 | 46.30% |
| Sep 30, 2019 | 31.55% |
| Jun 30, 2019 | 39.04% |
| Mar 31, 2019 | 31.15% |
| Dec 31, 2018 | 29.43% |
| Sep 30, 2018 | 17.58% |
| Jun 30, 2018 | 41.07% |
| Mar 31, 2018 | 37.68% |
| Dec 31, 2017 | 38.07% |
| Sep 30, 2017 | 34.94% |
| Jun 30, 2017 | 39.86% |
| Mar 31, 2017 | 35.87% |
| Dec 31, 2016 | 44.22% |
| Sep 30, 2016 | 50.31% |
| Jun 30, 2016 | 51.30% |
| Mar 31, 2016 | 49.69% |
| Dec 31, 2015 | 72.95% |
| Sep 30, 2015 | 47.07% |
| Jun 30, 2015 | 58.17% |
| Mar 31, 2015 | 33.59% |
| Dec 31, 2014 | 26.25% |
| Sep 30, 2014 | 63.82% |
| Jun 30, 2014 | 27.36% |
| Mar 31, 2014 | 22.99% |
| Dec 31, 2013 | 34.91% |
| Sep 30, 2013 | 16.72% |
| Jun 30, 2013 | 17.51% |
| Mar 31, 2013 | 16.67% |
| Dec 31, 2012 | 10.67% |
| Sep 30, 2012 | 6.84% |
| Jun 30, 2012 | 3.77% |
| Mar 31, 2012 | -1.51% |
| Dec 31, 2011 | 4.64% |
| Sep 30, 2011 | 33.89% |
| Jun 30, 2011 | 4,114.06% |
| Mar 31, 2011 | 100.00% |
| Dec 31, 2010 | 100.00% |
| Sep 30, 2010 | 100.00% |
| Jun 30, 2010 | 100.00% |